Search Results 181-190 of 17022 for Fibroma

  1. Uterine fibroids - Doctors and departments - Mayo Clinic

    Mayo Clinic researchers are involved in all areas of uterine fibroid research. In addition to studying the latest in diagnosis and treatment, Mayo Clinic ...

  2. Uterine fibroids - Doctors and departments - Mayo Clinic

    Research. Mayo Clinic researchers are involved in all areas of uterine fibroid research. In addition to studying the latest in diagnosis and treatment, ...

  3. Fibromuscular dysplasia - Doctors and departments - Mayo Clinic

    Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, Florida and Minnesota. Staff skilled in dozens ...

  4. Uterine fibroids - Doctors and departments - Mayo Clinic

    Mayo Clinic researchers are involved in all areas of uterine fibroid research. In addition to studying the latest in diagnosis and treatment, Mayo Clinic ...

  5. Uterine fibroids - Doctors and departments - Mayo Clinic

    Learn about these common noncancerous growths and what to do if you have symptoms such as heavy menstrual bleeding.

  6. A Study to Establish a Cystic Fibrosis Patient Registry for Mayo Clinic Jacksonville, Fl

    The purpose of this study is to collect data on individuals with cystic fibrosis (CF) to better understand the illness and ultimately improve the care and ...

  7. JavaScript is disabled. In order to continue, we need to verify that you're not a robot. This requires JavaScript. Enable JavaScript and then reload the page.

  8. Neurofibromatosis type 1 - Doctors and departments - Mayo Clinic

    This genetic condition causes tumors on nerve tissue. Surgery and other therapies can manage symptoms.

  9. Fibromuscular dysplasia - Doctors and departments - Mayo Clinic

    Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, Florida and Minnesota. Staff skilled in dozens ...

  10. A Study to Assess the Safety and Tolerability of CFT8634 in Locally Advanced or Metastatic SMARCB1-Perturbed Cancers, Including Synovial Sarcoma and SMARCB1-Null Tumors - Mayo Clinic

    Phase 2 only: To assess preliminary antitumor activity by overall response rate (ORR) as measured by Response Evaluation Criteria in Solid Tumors (RECIST) v1.1 ...